22.418 articles found

Levodopa in the treatment of Parkinson's disease.

Fahn S.

J Neural Transm Suppl · 2006-01-01

DOI: 10.1007/978-3-211-33328-0_1PMID: 17447410

Changing dopamine agonist treatment in Parkinson's disease: experiences with switching to pramipexole.

Reichmann H, Odin P, Brecht HM, Köster J, Kraus PH.

J Neural Transm Suppl · 2006-01-01

DOI: 10.1007/978-3-211-33328-0_2PMID: 17447411

The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.

Müller T, Welnic J, Fuchs G, Baas H, Ebersbach G, Reichmann H.

J Neural Transm Suppl · 2006-01-01

DOI: 10.1007/978-3-211-33328-0_3PMID: 17447412

PD-related psychosis: pathophysiology with therapeutical strategies.

Wolters ECh.

J Neural Transm Suppl · 2006-01-01

DOI: 10.1007/978-3-211-33328-0_4PMID: 17447413

Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy.

Qureshi GA, Qureshi AA, Memon SA, Parvez SH.

J Neural Transm Suppl · 2006-01-01

DOI: 10.1007/978-3-211-33328-0_24PMID: 17447433

A model-based approach for assessing parkinsonian gait and effects of levodopa and deep brain stimulation.

Cho C, Osaki Y, Kunin M, Cohen B, Olanow CW, Raphan T.

Conf Proc IEEE Eng Med Biol Soc · 2006-01-01

DOI: 10.1109/iembs.2006.259439PMID: 17946882

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Skovronsky DM, Lee VM, Trojanowski JQ.

Annu Rev Pathol · 2006-01-01

DOI: 10.1146/annurev.pathol.1.110304.100113PMID: 18039111

Respiratory stem cells and progenitors: overview, derivation, differentiation, carcinogenesis, regeneration and therapeutic application.

Kannan S, Wu M.

Curr Stem Cell Res Ther · 2006-01-01

DOI: 10.2174/157488806775269115PMID: 18220852

Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.

Bonsi P, Cuomo D, Martella G, Sciamanna G, Tolu M, Calabresi P, Bernardi G, Pisani A.

Curr Neuropharmacol · 2006-01-01

DOI: 10.2174/157015906775203039PMID: 18615133

Parkinson therapeutic equipment

ZHANG JINLU XU.

· 2005-12-28

Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment.

Hazell AS, Normandin L, Norenberg MD, Kennedy G, Yi JH.

Neurosci Lett · 2005-12-27

DOI: 10.1016/j.neulet.2005.11.064PMID: 16384640

TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS USING POSTPARTUM DERIVED CELLS

MESSINA Darin J., MISTRY Sanjay, HONG L.S. Klaudyne, KRAMER Brian C., ROMANKO Michael J..

· 2005-12-22